AN AREA of Scotland has been revealed as a world hotspot for Huntington’s disease. New research has revealed the shockingly ...

The US Food and Drug Administration (FDA) has awarded breakthrough therapy designation to uniQure's AMT-130 for treating ...

Qure's AMT-130 gene therapy for Huntington’s Disease shows promising trial data. Check out my recommendation for QURE stock.

Northern Scotland has one of the highest rates of Huntington’s disease in the world, a study has found. The number of people ...

AMT-130 is administered through magnetic resonance imaging-guided, convection-enhanced stereotactic neurosurgical delivery into the striatum.

The flight, carrying celebrities like Katy Perry and Gayle King, reached a height of about 60 miles (96.6km) above Earth.

Sandy Patience says he is 'proud to break the mould' and take part in a clinical trial to develop treatments for Huntington's ...

"Pridopidine shows long-term sustained efficacy up to 2 years, and there's significant long-term benefit confirmed compared ...

Dublin, April 18, 2025 (GLOBE NEWSWIRE) -- The "Huntington's Disease Treatment Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033" has been added to ResearchAndMarkets ...

Qure's long-term success hinges on overcoming regulatory and logistical challenges. See why I rate QURE stock a hold.